Literature DB >> 18682602

IFN-{gamma}-mediated inhibition of MAPK phosphatase expression results in prolonged MAPK activity in response to M-CSF and inhibition of proliferation.

Annabel F Valledor1, Luís Arpa, Ester Sánchez-Tilló, Mònica Comalada, Cristina Casals, Jordi Xaus, Carme Caelles, Jorge Lloberas, Antonio Celada.   

Abstract

Macrophages have the capacity to proliferate in response to specific growth factors, such as macrophage-colony stimulating factor (M-CSF). In the presence of several cytokines and activating factors, macrophages undergo growth arrest, become activated, and participate in the development of an immune response. We have previously observed that activation of extracellularly regulated kinase 1/2 (ERK-1/2) is required for macrophage proliferation in response to growth factors. A short and early pattern of ERK activity correlated with the proliferative response. In contrast, slightly prolonged patterns of activity of these kinases were induced by signals that lead to macrophage activation and growth arrest. IFN-gamma is the main endogenous Th1-type macrophage activator. Here we report that stimulation with IFN-gamma prolongs the pattern of ERK activity induced by M-CSF in macrophages. These effects correlate with IFN-gamma-mediated inhibition of the expression of several members of the MAPK phosphatase family, namely MKP-1, -2, and -4. Moreover, inhibition of MKP-1 expression using siRNA technology or synthetic inhibitors also led to elongated ERK activity and significant blockage of M-CSF-dependent proliferation. These data suggest that subtle changes in the time course of activity of members of the MAPK family contribute to the antiproliferative effects of IFN-gamma in macrophages.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18682602     DOI: 10.1182/blood-2007-11-123604

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  18 in total

1.  Matrix metalloproteinase-9 and cell division in neuroblastoma cells and bone marrow macrophages.

Authors:  M Gloria Sans-Fons; Sonia Sole; Coral Sanfeliu; Anna M Planas
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

Review 2.  Mitogen-activated protein kinase phosphatase 1 (MKP-1) in macrophage biology and cardiovascular disease. A redox-regulated master controller of monocyte function and macrophage phenotype.

Authors:  Hong Seok Kim; Reto Asmis
Journal:  Free Radic Biol Med       Date:  2017-03-19       Impact factor: 7.376

3.  Mitogen-activated protein kinase phosphatase-1 deficiency decreases atherosclerosis in apolipoprotein E null mice by reducing monocyte chemoattractant protein-1 levels.

Authors:  Satoshi Imaizumi; Victor Grijalva; Saul Priceman; Lily Wu; Feng Su; Robin Farias-Eisner; Susan Hama; Mohamad Navab; Alan M Fogelman; Srinivasa T Reddy
Journal:  Mol Genet Metab       Date:  2010-06-09       Impact factor: 4.797

Review 4.  Mitogen-activated protein kinase phosphatase (MKP)-1 in immunology, physiology, and disease.

Authors:  Lyn M Wancket; W Joshua Frazier; Yusen Liu
Journal:  Life Sci       Date:  2011-12-13       Impact factor: 5.037

5.  Profiling Subcellular Protein Phosphatase Responses to Coxsackievirus B3 Infection of Cardiomyocytes.

Authors:  Millie Shah; Christian M Smolko; Sarah Kinicki; Zachary D Chapman; David L Brautigan; Kevin A Janes
Journal:  Mol Cell Proteomics       Date:  2017-02-07       Impact factor: 5.911

6.  Triptolide Inhibits the Proliferation of Immortalized HT22 Hippocampal Cells Via Persistent Activation of Extracellular Signal-Regulated Kinase-1/2 by Down-Regulating Mitogen-Activated Protein Kinase Phosphatase-1 Expression.

Authors:  Hee Sang Koo; Sung Don Kang; Ju Hwan Lee; Nam-Ho Kim; Hun-Taeg Chung; Hyun-Ock Pae
Journal:  J Korean Neurosurg Soc       Date:  2009-10-31

7.  MAP kinase phosphatase-1, a critical negative regulator of the innate immune response.

Authors:  Liwu Li; Shuang-Feng Chen; Yusen Liu
Journal:  Int J Clin Exp Med       Date:  2009-02-15

8.  microRNA expression pattern modulates temozolomide response in GBM tumors with cancer stem cells.

Authors:  Gulcin Tezcan; Berrin Tunca; Ahmet Bekar; Matthias Preusser; Anna Sophie Berghoff; Unal Egeli; Gulsah Cecener; Gerda Ricken; Ferah Budak; Mevlut Ozgur Taskapılıoglu; Hasan Kocaeli; Sahsine Tolunay
Journal:  Cell Mol Neurobiol       Date:  2014-04-02       Impact factor: 5.046

Review 9.  Mitogen-activated protein kinases in innate immunity.

Authors:  J Simon C Arthur; Steven C Ley
Journal:  Nat Rev Immunol       Date:  2013-08-19       Impact factor: 53.106

10.  In vivo inhibition of c-MYC in myeloid cells impairs tumor-associated macrophage maturation and pro-tumoral activities.

Authors:  Oscar M Pello; Raphael Chèvre; Damya Laoui; Alba De Juan; Fidel Lolo; María Jesús Andrés-Manzano; Manuel Serrano; Jo A Van Ginderachter; Vicente Andrés
Journal:  PLoS One       Date:  2012-09-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.